The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo

Circulation Research

Volumn 88, Issue 1, 2001, Pages 88-96

  Bueno, Orlando F ^a   De Windt, Leon J ^a   Lim, Hae W ^a   Tymitz, Kevin M ^a   Witt, Sandra A ^a   Kimball, Thomas R ^a   Molkentin, Jeffery D ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cardiac function; Hypertrophy; Mice, transgenic; Mitogen activated protein kinase; Phosphatase

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME SPECIFICITY; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0035910603     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.88.1.88     Document Type: Article

References (35)

1. Prevention of cardiac hypertrophy by calcineurin inhibition
2. Gq signaling in cardiac adaptation and maladaptation
3. Signaling pathways for cardiac hypertrophy and failure
4. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
5. Mitogen-activated protein kinase phosphatase: A negative regulator of the mitogen-activated protein kinase cascade
6. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation
7. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells
8. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways
9. Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinase
10. Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes
11. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium
12. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure
13. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
14. Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism
15. Ablation of the murine α myosin heavy chain gene leads to dosage effects and functional deficits in the heart
16. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family
17. 2-terminal kinases
18. Activation of JNK in the remote myocardium after large myocardial infarction in rats
19. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion
20. Effects of chronic β-adrenergic receptor stimulation in mice
21. Cell density and contraction regulate p38 MAP kinase-dependent responses in neonatal rat cardiac myocytes
22. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes
23. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: A role in cardiac myocyte hypertrophy?
24. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy
25. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy
26. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes
27. 1-adrenergic receptor and ras activation and is associated with in vitro and in vivo cardiac hypertrophy
28. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression
29. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy
30. Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes
31. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease
32. 2-terminal kinase in ventricular muscle cells
33. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy
34. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
35. Many pathways to cardiac hypertrophy